Cite
HARVARD Citation
Bokemeyer, C. et al. (2021). Impact of Disease Evolution on Efficacy Outcomes From Larotrectinib in Patients With Locally Advanced or Metastatic Tropomyosin Receptor Kinase Fusion–Positive Solid Tumors. JCO precision oncology. p. . [Online].